L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke
Authors:
- 31 January 2023
- journal article
- research article
- Published by Springer Nature in Pharmacological Reports
- Vol. 75 (2) , 276-292
Abstract
Background L-proline transporter (PROT/SLC6A7) is closely associated with glutamatergic neurotransmission, where L-proline modulates the NMDA receptor (NMDAR) function. NMDAR-mediated excitotoxicity is a primary cause of neuronal death following stroke, which is triggered by the uncontrolled release of glutamate during the ischemic process. After ischemic stroke, L-proline levels show a reduction in the plasma, but high circulating levels of this molecule indicate good functional recovery. This work aimed to produce new PROT inhibitors and explore their effects on ischemic stroke. Methods Initially, we built a three-dimensional model of the PROT protein and run a molecular docking with the newly designed compounds (LQFM215, LQFM216, and LQFM217). Then, we synthesized new PROT inhibitors by molecular hybridization, and proline uptake was measured in ex vivo and in vivo models. The behavioral characterization of the treated mice was performed by the open-field test, elevated plus-maze, Y-maze, and forced swimming test. We used the permanent middle cerebral artery occlusion (MCAO) model to study the ischemic stroke damage and analyzed the motor impairment with limb clasping or cylinder tests. Results LQFM215 inhibited proline uptake in hippocampal synaptosomes, and the LQFM215 treatment reduced proline levels in the mouse hippocampus. LQFM215 reduced the locomotor and exploratory activity in mice and did not show any anxiety-related or working memory impairments. In the MCAO model, LQFM215 pre-treatment and treatment reduced the infarcted area and reduced motor impairments in the cylinder test and limb clasping. Conclusions This dataset suggests that the new compounds inhibit cerebral L-proline uptake and that LQFM215 promotes neuroprotection and neuro-repair in the acute ischemic stroke model. Graphical abstractKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Goiás (88887.305550/2018-00)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (406765/2021-9, 407075/2018-6, 406048/2018-5)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ-00820-17)
This publication has 47 references indexed in Scilit:
- Avogadro: an advanced semantic chemical editor, visualization, and analysis platformJournal of Cheminformatics, 2012
- Repeated brief episodes of hypoxia modulate the calcium responses of ionotropic glutamate receptors in hippocampal neuronsNeuroscience Letters, 2011
- QMEAN server for protein model quality estimationNucleic Acids Research, 2009
- Looking for novel ways to treat the hallmarks of Alzheimer's diseaseExpert Opinion on Investigational Drugs, 2007
- Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) UpregulationStroke, 2007
- Cerebral preconditioning and ischaemic toleranceNature Reviews Neuroscience, 2006
- Neuroprotective Effects of Preconditioning Ischemia on Ischemic Brain Injury through Down-regulating Activation of JNK1/2 via N-Methyl-D-aspartate Receptor-mediated Akt1 ActivationJournal of Biological Chemistry, 2005
- NMDA Preconditioning Protects against Seizures and Hippocampal Neurotoxicity Induced by Quinolinic Acid in MiceEpilepsia, 2004
- Sequestering Ability of Butylated Hydroxytoluene, Propyl Gallate, Resveratrol, and Vitamins C and E against ABTS, DPPH, and Hydroxyl Free Radicals in Chemical and Biological SystemsJournal of Agricultural and Food Chemistry, 2003
- Molecular cloning and expression of a high affinity l -proline transporter expressed in putative glutamatergic pathways of rat brainNeuron, 1992